סימבקסון 40

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

SIMVASTATIN

可用日期:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC代码:

C10AA01

药物剂型:

קפליות

组成:

SIMVASTATIN 40 MG

给药途径:

פומי

处方类型:

מרשם נדרש

厂商:

DEXCEL LTD, ISRAEL

治疗组:

SIMVASTATIN

治疗领域:

SIMVASTATIN

疗效迹象:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

產品總結:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

授权日期:

2020-04-30